National Cancer Institute

Some Postmenopausal Women with Breast Cancer May Forgo Chemotherapy

Postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to a limited number of lymph nodes, and whose recurrence risk is [...]

Please help us continue providing our vital cancer support services…

Donate Today